Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy-Reference-Cited by-同舟云学术

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

Published:2002-06 Issue:1-2 Volume:50 Page:105-123
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Löscher Wolfgang

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference77 articles.

1. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy;André;Epilepsy Res.,2001

2. Causes of epilepsy: contributions of the Rochester epidemiology project;Annegers;Mayo Clin. Proc.,1996

3. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy;Barton;Epilepsy Res.,2002

4. Advances in the medical treatment of epilepsy;Bazil;Annu. Rev. Med.,1998

5. Comparison of valproate and phenobarbital treatment after status epilepticus in rats;Bolanos;Neurology,1998

Cited by 434 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mammalian models of status epilepticus – Their value and limitations;Epilepsy & Behavior;2024-09

2. Susceptibility to Pentylenetetrazole-Induced Seizures in Mice with Distinct Activity of the Endogenous Opioid System;International Journal of Molecular Sciences;2024-06-26

3. Pathophysiological and therapeutic implications of neuropeptide S system in neurological disorders;Peptides;2024-05

4. Glutamatergic Neurotransmission and Toxicity: Domoic Acid and Kainic Acid (Glutamic Acid Analogs);Neurotransmitters and Toxicology;2024-05-01

5. Unveiling the Anti-convulsant Potential of Novel Series of 1,2,4-Triazine- 6H-Indolo[2,3-b]quinoline Derivatives: In Silico Molecular Docking, ADMET, DFT, and Molecular Dynamics Exploration;Current Computer-Aided Drug Design;2023-12